Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Leading contract manufacturing drug firm Akums Drugs and Pharmaceuticals Ltd on Wednesday (May 20) said its subsidiary Akumentis Healthcare Ltd and the company have received assessment orders under Section 158BC of the Income Tax Act, 1961, for the block period from April 1, 2018, to March 12, 2025. Akums Drugs received a tax demand of…
